
Vively
Unlocks the powers of lifestyle medicine for people with chronic conditions.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $1.6m | Seed | |
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Vively is a metabolic health platform that offers a continuous glucose monitoring (CGM) program combined with a mobile application. The company's primary service is to provide users with real-time data on their glucose levels and how they are affected by food, exercise, and sleep.
The platform is targeted towards individuals seeking to manage their weight, improve energy levels, and reduce their risk of metabolic diseases. Vively's business model is subscription-based, offering quarterly and annual plans for their CGM program. The program includes a CGM sensor and access to the Vively app, which provides personalized insights, macro and weight tracking, and a 'Wellness Score' to measure metabolic health.
The company operates in the health and wellness market, specifically in the growing sector of personalized health technology. By leveraging AI and health data, Vively aims to empower users to take control of their metabolic health through data-driven insights and guidance. The service is positioned as a general wellness platform and does not provide medical advice.
Keywords: continuous glucose monitoring, metabolic health, personalized nutrition, health technology, subscription service, wellness platform, mobile health, data-driven health, AI in health, preventative health
Tech stack
Investments by Vively
Edit